Dong-A to complete Phase 3 clinical trial over new natural drug

Published: 2009-11-04 06:59:00

Updated: 2009-11-04 06:59:00

Dong-A Pharmaceutical is set to complete its Phase 3 study of a herbal medicine for those with functional dyspepsia in the first half of next year, according to the Ministry of Education, Science and Technology.

The results of Phase II study in Korean patients showed that DA-9701 is effective ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK